Many of these proteins are overexpressed in various cancer types and are linked to poor patient prognosis, tumor growth, invasion, and metastasis through signaling pathways such as MAPK, PI3K/AKT, and AMPK (Borah and Reddy, 2021; Qiu et al., 2021). This evidence concerns the gene AKT1 and neoplasm.